Follow
Serena Marchiò
Serena Marchiò
Department of Oncology, University of Turin School of Medicine, Candiolo, Italy
Verified email at unito.it - Homepage
Title
Cited by
Cited by
Year
c-fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro
L Marconcini, S Marchiò, L Morbidelli, E Cartocci, A Albini, M Ziche, ...
Proceedings of the National Academy of Sciences 96 (17), 9671-9676, 1999
3861999
PRUNE2 is a human prostate cancer suppressor regulated by the intronic long noncoding RNA PCA3
A Salameh, AK Lee, M Cardó-Vila, DN Nunes, E Efstathiou, FI Staquicini, ...
Proceedings of the National Academy of Sciences 112 (27), 8403-8408, 2015
2722015
Overexpression of the RON gene in human breast carcinoma
P Maggiora, S Marchio, MC Stella, M Giai, A Belfiore, MD Bortoli, ...
Oncogene 16 (22), 2927-2933, 1998
2681998
Ligand-targeted theranostic nanomedicines against cancer
VJ Yao, S D'Angelo, KS Butler, C Theron, TL Smith, S Marchiò, ...
Journal of Controlled Release 240, 267-286, 2016
2072016
Aminopeptidase A is a functional target in angiogenic blood vessels
S Marchiò, J Lahdenranta, RO Schlingemann, D Valdembri, P Wesseling, ...
Cancer cell 5 (2), 151-162, 2004
1592004
Vascular endothelial growth factor-C stimulates the migration and proliferation of Kaposi's sarcoma cells
S Marchio, L Primo, M Pagano, G Palestro, A Albini, T Veikkola, I Cascone, ...
Journal of Biological Chemistry 274 (39), 27617-27622, 1999
1321999
The combination of sorafenib and everolimus abrogates mTORC1 and mTORC2 upregulation in osteosarcoma preclinical models
Y Pignochino, C Dell'Aglio, M Basiricò, F Capozzi, M Soster, S Marchiò, ...
Clinical Cancer Research 19 (8), 2117-2131, 2013
1222013
Identification of CD36 molecular features required for its in vitro angiostatic activity
L Primo, C Ferrandi, C Roca, S Marchiò, L Di Blasio, M Alessio, ...
The FASEB journal 19 (12), 1713-1715, 2005
1052005
Luminescent silica nanoparticles for cancer diagnosis
W Arap, R Pasqualini, M Montalti, L Petrizza, L Prodi, E Rampazzo, ...
Current medicinal chemistry 20 (17), 2195-2211, 2013
922013
Combined targeting of perivascular and endothelial tumor cells enhances anti-tumor efficacy of liposomal chemotherapy in neuroblastoma
M Loi, S Marchiò, P Becherini, D Di Paolo, M Soster, F Curnis, C Brignole, ...
Journal of controlled release 145 (1), 66-73, 2010
902010
BCAM and LAMA5 mediate the recognition between tumor cells and the endothelium in the metastatic spreading of KRAS-mutant colorectal cancer
A Bartolini, S Cardaci, S Lamba, D Oddo, C Marchiò, P Cassoni, ...
Clinical cancer research 22 (19), 4923-4933, 2016
802016
SERS active Ag nanoparticles in mesoporous silicon: detection of organic molecules and peptide–antibody assays
A Virga, P Rivolo, E Descrovi, A Chiolerio, G Digregorio, F Frascella, ...
Journal of Raman Spectroscopy 43 (6), 730-736, 2012
732012
Angiopoietin-like 7, a novel pro-angiogenetic factor over-expressed in cancer
M Parri, L Pietrovito, A Grandi, S Campagnoli, E De Camilli, F Bianchini, ...
Angiogenesis 17, 881-896, 2014
642014
Cell surface–associated Tat modulates HIV-1 infection and spreading through a specific interaction with gp120 viral envelope protein
S Marchio, M Alfano, L Primo, D Gramaglia, L Butini, L Gennero, ...
Blood 105 (7), 2802-2811, 2005
612005
A complex of α6 integrin and E‐cadherin drives liver metastasis of colorectal cancer cells through hepatic angiopoietin‐like 6
S Marchio, M Soster, S Cardaci, A Muratore, A Bartolini, V Barone, ...
EMBO molecular medicine 4 (11), 1156-1175, 2012
552012
Targeted dual-color silica nanoparticles provide univocal identification of micrometastases in preclinical models of colorectal cancer
M Soster, R Juris, S Bonacchi, D Genovese, M Montalti, E Rampazzo, ...
International Journal of Nanomedicine, 4797-4807, 2012
552012
Targeted molecular-genetic imaging and ligand-directed therapy in aggressive variant prostate cancer
F Ferrara, DI Staquicini, WHP Driessen, S D’Angelo, AS Dobroff, M Barry, ...
Proceedings of the National Academy of Sciences 113 (45), 12786-12791, 2016
532016
Novel phage display-derived neuroblastoma-targeting peptides potentiate the effect of drug nanocarriers in preclinical settings
M Loi, D Di Paolo, M Soster, C Brignole, A Bartolini, L Emionite, J Sun, ...
Journal of controlled release 170 (2), 233-241, 2013
522013
Emerging pharmacologic targets in cerebral cavernous malformation and potential strategies to alter the natural history of a difficult disease: a review
MO Chohan, S Marchiò, LA Morrison, RL Sidman, WK Cavenee, ...
JAMA neurology 76 (4), 492-500, 2019
492019
Self-targeting of TNF-releasing cancer cells in preclinical models of primary and metastatic tumors
E Dondossola, AS Dobroff, S Marchiò, M Cardó-Vila, H Hosoya, SK Libutti, ...
Proceedings of the National Academy of Sciences 113 (8), 2223-2228, 2016
462016
The system can't perform the operation now. Try again later.
Articles 1–20